Anixa Biosciences ANIX shares gained 13% on Wednesday following the announcement that the U.S. Patent and Trademark Office ...

On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to ...

In other recent news, Anixa Biosciences has made significant strides in their financial and clinical developments. The company reported a net loss of $3.1 million for the second fiscal quarter of ...

Anixa Biosciences, Inc.’s ANIX share price has surged by 7.56%, which has investors questioning if this is right time to sell.

Anixa Biosciences (ANIX) announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for a new ...

Anixa Biosciences (ANIX) has entered into a letter of intent with Verdi Solutions to develop personalized and off-the-shelf peptide vaccines ...

(RTTNews) - Anixa Biosciences, Inc. (ANIX), a biotechnology company focused on the treatment and prevention of cancer, Monday announced that it has received a Notice of Allowance from the United ...

The latest price target for Anixa Biosciences (NASDAQ:ANIX) was reported by D. Boral Capital on March 26, 2025. The analyst firm set a price target for $10.00 expecting ANIX to rise to within 12 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...